Appointed John H. Johnson as Executive Chairman; Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer; and Reena Thomas Colacot as Vice ...

LONDON (Reuters) -Trump administration cuts across federal health agencies have sent shivers through a biotech industry ...

Mirum announced the FDA approved a new tablet formulation of Livmarli for the treatment of cholestatic pruritus in patients with Alagille ...

Fate Therapeutics (NASDAQ:FATE) gets FDA RMAT designation for FT819, an experimental CAR T-cell therapy for lupus. Read more ...